CANCELED First Annual Developmental Therapeutics and Precision Medicine Symposium

Milwaukee, WI US
May 15, 2020

Dear Colleagues,

In light of the Covid-19 pandemic, we have decided to postpone the 'First Annual MCW Developmental Therapeutics and Precision Medicine Symposium' scheduled on 5/15/2020. Planning for the symposium will commence when the situation is deemed safe enough and a new date will be announced. 

Hope all of you stay healthy and safe!

Best,
Ben George

On behalf of the planning committee: 

Emily Lemke, DNP, AGPCNP-BC, AOCNP
Sailaja Kamaraju, ND
Deepak Kilari, MD
Matthew Riese, MD, PhD
Katy Schroeder
Aditya Shreenivas, MD, MS
Jonathan Thompson, MD, MS

 

This one-day symposium will provide education for medical oncologists and allied healthcare providers about advances in precision medicine and developmental therapeutics. Our expert faculty will discuss the latest developments in precision medicine and novel therapies in breast, lung, gastrointestinal and genitourinary cancers aimed at updating both academic and community healthcare providers.

Target Audience

Physicians, Physician Assistants, Nurse Practitioners,  Registered Nurses, Allied Health Professionals and Researchers

Learning Objectives

  1. Review promising new developments in breast, lung, gastrointestinal and genitourinary cancers
  2. Review the developmental therapeutics and precision medicine program, specifically clinical trails at Froedtert and MCW for patients with advanced cancer
  3. Identify barriers to implementation of precision cancer therapeutics and early phase trial enrollment
Additional information

CME Coordinator Contact Information

Name: 
Dan Bullock
Phone Number: 
+1 (414) 805-4617
Course summary
Available credit: 
  • 4.00 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 4.00 Hours of Participation
    Hours of Participation credit.
  • 0.00 NP Pharmacology
    NP Pharmacology credit.
  • 4.00 NP Contact Hours
Course opens: 
02/24/2020
Course expires: 
07/15/2020
Event starts: 
05/15/2020 - 11:30am
Event ends: 
05/15/2020 - 4:45pm
Cost:
$0.00

 

11:30 am – 12:15pm                 Registration/Lunch/View Exhibits
 
12:15pm                                   Introduction
 
12:15 - 1:00pm                         Mechanisms of Resistance to CDK4/6 Inhibitors and New Therapeutic Approaches in the Treatment of Breast Cancer
Sarat Chandarlapaty, MD, PhD, Memorial Sloan Kettering Cancer Center
 
1:00 – 1:45pm                          Immunotherapy Combinations and Sequence of Treatment in Renal Cancer
Bryan Rini, MD, Cleveland Clinic
 
1:45 – 2:00pm                          Break
 
2:00 – 2:30pm                          Froedtert & the Medical College of Wisconsin Developmental Therapeutics & Precision Medicine Program
Ben George, MD |Katy Schroeder
 
2:30pm – 3:15pm                     Early Phase Therapeutics in Development for Lung Cancer
Melissa Johnson, MD
 
3:15 – 4:00pm                          Predictive and Prognostic Biomarkers in CRC and Evolving Treatment Strategies
Christopher Lieu, MD
 
4:00 – 4:30pm                          Barriers to Effective Implementation of Precision Cancer Therapeutics and Early Phase Trial
                                                Enrollment: A Real World Perspective
Panel: Adedayo Onitilo, MD, PhD, MSCR |David Knight, MD |Xin Yao, MD |Christopher Peterson, MD
 
4:30pm                                    Adjourn
The University Club
924 E. Wells Street
Milwaukee, WI 53202
United States
+1 (414) 930-1865

Complimentary parking will be available in the attached structure for all attendees.

Guest Speakers

Sarat Chandarlapaty, MD, PhD
Section head, Translational Research
Memorial Sloan Kettering Cancer Center
 
Melissa Johnson, MD
Associate Director,
Lung Cancer Research
Sarah Cannon Research Institute
 
Christopher Lieu, MD
Associate Professor of Medicine
Division of Medical Oncology
University of Colorado
 
Brian Rini, MD
Professor of Medicine
Chief, Cancer Clinical Trials
Division of Hematology and Oncology
Vanderbilt University
 
Guest Panelists
David Knight, MD, PhD, Froedtert South
Adedayo Onitilo, MD, PhD, MSCR, FACP, Marshfield Clinic Research Institute
Christopher Peterson, MD, Aspirus Regional Cancer Center
Xin Yao, MD, ThedaCare Cancer Center

Planning Committee

Ben George, MD
Associate Professor of Medicine
Division of Hematology and Oncology
Medical College of Wisconsin
 
Sailaja Kamaraju, MD
Assistant Professor of Medicine
Division of Hematology and Oncology
Medical College of Wisconsin
 
Deepak Kilari, MD
Associate Professor of Medicine
Division of Hematology and Oncology
Medical College of Wisconsin
 
Emily Lemke, DNP, AGPCNP-BC, AOCNP
Nurse Practitioner
Division of Hematology and Oncology
Medical College of Wisconsin
 
Matthew Riese, MD, PhD
Associate Professor of Medicine
Division of Hematology and Oncology
Medical College of Wisconsin
 
Katy Schroeder
Early Phase Research Manager
Medical College of Wisconsin
 
Aditya Shreenivas, MD, MS
Assistant Professor of Medicine
Division of Hematology and Oncology
Medical College of Wisconsin
 
Jonathan Thompson, MD, MS
Assistant Professor of Medicine
Division of Hematology and Oncology
Medical College of Wisconsin

Dan Bullock
Education Program Coordinator
Division of Hematology and Oncology
Medical College of Wisconsin


All persons in control of content have NO relevant financial relationships to dislose with the exception of:

NameCompanyRole
   

In accordance with the ACCME® standards for Commercial Support Number 6, all in control of content disclosed any relevant financial relationships. These relationships were reviewed via the MCW conflict of interest resolution process and resolved.

ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement:
The Medical College of Wisconsin designates this live activity for a maximum of 4.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Hours of Participation for Allied Health Care Professionals:
The Medical College of Wisconsin designates this activity for up to 4.0 hours of participation for continuing education for allied health professionals.

Nurse Practitioners:
Medical College of Wisconsin, Inc. is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners: AANP Provider Number 150930.  This program has been approved for 4.0 contact hours of continuing education (which includes 0 hours of pharmacology).

 

Available Credit

  • 4.00 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 4.00 Hours of Participation
    Hours of Participation credit.
  • 0.00 NP Pharmacology
    NP Pharmacology credit.
  • 4.00 NP Contact Hours

Price

Cost:
$0.00
Please login or register to take this course.

This activity is complementary, however registration is required. To register for this course click the "Take Course" button above.